news & initiatives

United with a common goal - Global Healthcare!

Trivitron Healthcare and IFHA Launch an Innovative New Medical Technology Joint Venture Focused on the African Continent

30 - January - 2018

Dubai, UAE. January 30, 2018 – Trivitron Healthcare Private Limited (“Trivitron”), India’s leading medical technology company, together with the Investment Funds for Health in Africa (“IFHA”), a leading private equity investor in the healthcare sector in Africa, are excited to announce the launch of Trivitron Healthcare Africa B.V. (“THA”), a new medical technology company focused on the African continent.  THA will provide high-quality medical devices and instruments with reliable after-sales service support across Africa, thereby improving access and affordability of medical equipment across the continent.

In its first phase of operations, Trivitron Healthcare Africa will be headquartered in Dubai, United Arab Emirates, with a direct presence and sales and service infrastructure in four major hubs: Nairobi, Kenya; Johannesburg, South Africa; Lagos, Nigeria and Algiers, Algeria.  The company will leverage these hubs to support neighboring countries and manage an extensive channel partner network across the African continent.  

THA’s initial offering will include a complete range of products and after-sales service support in laboratory medicine, medical imaging, critical care, operating room and renal care.  The company will not only distribute and support products manufactured by Trivitron in their nine USFDA, CE certified factories in India, Finland, and Turkey; but it will also distribute and support products from other leading multinational corporations.  

In addition, THA will have an exclusive Projects division capable of executing turnkey hospital projects in the African continent.  THA is already working with a leading healthcare group in East Africa to support the design and equipping of its new flagship hospital in Nairobi, Kenya.  The company will also have a Multi-Vendor Biomedical Engineering Services division to ensure support for healthcare providers across Africa, and focus on academic initiatives, offering paramedical and super specialty support courses in association with reputed academic institutions from India and Europe.

THA is in advanced discussions with the International Finance Corporation (“IFC”), a member of the World Bank Group and investor in many of the leading healthcare providers in Sub-Saharan Africa, for a debt investment to support its growth strategy.

Dr. GSK Velu, Chairman and Managing Director of Trivitron said, “This is a first of its kind venture between the leading medical technology company in India and a leading healthcare private equity investor in Africa, with support from IFC.” 

“IFHA has long seen an opportunity to improve access to quality healthcare services by creating a provider of high-quality, affordable medical equipment and services.  IFHA is excited to partner with Trivitron and IFC to turn this vision into a reality.” said Max Coppoolse, the Managing Partner of IFHA.

About Trivitron

Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare providers. Trivitron markets its products to hospitals, individual healthcare providers, independent clinics and laboratories, extended care facilities and all other roofs providing healthcare solutions. As a pioneer in the field, Trivitron constantly pursues technological innovations to offer superior clinical benefits at a lower cost. At Trivitron, quality healthcare is considered as a fundamental right and the vision is to make it available for the people of all classes.

Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 165 countries. A family of 1,500+ employees and the support of 1,200+ channel partners prepare the organization for unexpected challenges and aligns the company’s daily activities with its vision. With 9 USFDA, CE certified manufacturing facilities, supported by several R&D tie-ups with global leaders, Trivitron holds the record of 50,000+ installations across the globe. Today, Trivitron spearheads innovation in the fields of Newborn Screening, In-Vitro Diagnostics, Imaging & Radiology, Radiation Protection, Critical Care, Renal Care and Operating Room Solutions, thus, engraving its name as a holistic healthcare provider.


About IFHA

When it was launched in 2008 in Amsterdam, Netherlands, the Investment Funds for Health in Africa (IFHA) was the first private equity fund dedicated to investing in small and medium enterprises in the private healthcare sector in Africa.  Today, IFHA manages two funds with approximately $200 million of assets under management, focusing its investments across various healthcare segments including healthcare provision, health insurance, health management organizations, administration providers, purchasing companies, medical asset financing, pharmaceutical production and distribution, medical equipment distribution and medical education.  After nearly 10 years of operations, IFHA builds on its strong network and a solid track record of results from its first round investees, which include six successful exits. 


For further information, please contact:

Mr. Amit Arora, Corporate Communication, Trivitron at amit.arora@trivitron.com

Mr. Shayne Aman Premji, Director, IFHA at s.premji@ifhafund.com